XBIO

Xenetic Biosciences, Inc.

3.48 USD
-0.31 (-8.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Xenetic Biosciences, Inc. stock is down -0.85% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 11 February’s closed higher than January.

About Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC.